Baidu
map
PAIN PHYSICIAN 润色咨询

Pain Physician

出版年份:1999 年文章数:1615 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:18.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2024-08-01 ms653363634509373 来自北京

    2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2024-04-14 1521ee135cm 来自浙江省

    最近投稿网站进不去了,大家知道怎么回事吗

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2022-11-22 ms7000000471184589

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:疼痛;疼痛治疗技术;Meta分析
    经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2023-02-16 ms7000000388634182 来自安徽省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:Manuscript received: 07-30-2022
    Revised manuscript received:
    10-10-2022
    Accepted for publication:
    10-14-2022
    排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2019-05-14 cgzxzjy1_23539605

    审稿速度:2.0
    经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2022-08-24 441246801

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:疼痛治疗技术
    经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2022-06-16 1e18b22bm01(暂无匿称)

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:疼痛;微创;Meta分析
    经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-06-28 ms6000001442478095

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:微创;临床
    经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-12-14 12436392m12(暂无昵称)

    审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0
    偏重的研究方向:疼痛;麻醉;神经阻滞
    经验分享:Manuscript received: 12-23-2020
    Revised manuscript received:
    04-06-2021
    Accepted for publication:
    04-19-2021
    proof
    08-11-2021
    Free full manuscript

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2217893, encodeId=2d5a221e893c1, content=2023.11.12投稿,之后外审,2024.1.4直接接收,一个字都没有改。真是运气太好了,遇到了nice的审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608e1789707, createdName=ms653363634509373, createdTime=Thu Aug 01 00:06:51 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了,大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;疼痛治疗技术;Meta分析<br>经验分享:请问一下这个杂志是不是proof很慢?10月10号显示接收,到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:Manuscript received: 07-30-2022<br>Revised manuscript received:<br>10-10-2022<br>Accepted for publication:<br>10-14-2022<br>排的2023年一月刊,但是不知道什么时候能检索到?等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0<br>经验分享:2019.04.03投稿,04.08状态变为under review,05.10拒稿,没有任何审稿意见,应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛治疗技术<br>经验分享:4月28投稿,6月28通知大修,7月15修回,8月21显示审稿结束,等待编辑意见,到现在一直没有消息,会不会是被拒绝?暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:疼痛;微创;Meta分析<br>经验分享:杂志社很不错,也没有版面费。现在投稿要200美金(大约)的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:微创;临床<br>经验分享:现在好像要审稿费了,我是2020年投的稿。审稿4个多月吧,修了一次,两个审稿专家意见一致倾向于接收,修会就直接接收了。这本杂志唯一吐槽的是,正式接收后等proof等了6个多月,快7个月,proof结束后基本当月就见刊了,但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof,编辑的回复就是需要根据接收的顺序。这个杂志是双月刊,错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0<br>偏重的研究方向:疼痛;麻醉;神经阻滞<br>经验分享:Manuscript received: 12-23-2020<br>Revised manuscript received:<br>04-06-2021<br>Accepted for publication:<br>04-19-2021<br>proof<br>08-11-2021<br>Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0<br>偏重的研究方向:meta分析<br>经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=)]
    2021-09-17 12591680m53暂无昵称

    审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0
    偏重的研究方向:meta分析
    经验分享:年初投了一篇,meta分析,比较中规中矩,大修了一次录用,但录用后七个月才给见刊。好在不需要版面费。

    1

    展开1条回复
共45条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map